Hasil Pencarian  ::  Simpan CSV :: Kembali

"Background: low-grade chronic inflammation in obese individuals contributes to the development of lipid abnormality and insulin resistance. Vitamin E has antioxidant and insulin-sensitizing properties, mediated by adiponectin. In this study, we aimed to evaluate the effect of vitamin E supplementation on lipid profiles and adiponectin levels in obese adolescents.Methods: this was a randomized, double-blind, controlled study. Obese adolescents aged 14-18 years, with no history of taking anti-obesity or antioxidant drugs, were recruited and randomized into two groups: vitamin E and placebo. The dose of vitamin E was 400 IU/day. Intervention was administered for two months. Lipid profiles and adiponectin levels were measured at baseline and after intervention. Primary outcomes were analyzed using the per-protocol analysis principle. Statistical analysis was performed using the independent t-test or the Mann-Whitney U test.Results: a total of 66 subjects completed the intervention study, 34 in the vitamin E group and 32 in the placebo group. Lipid profiles and adiponectin levels at 2 months after intervention did not differ significantly between the two groups. Changes from the baseline level were also not significantly different between the two groups and were inconsistent from one subject to another.Conclusion: in obese adolescents, vitamin E supplementation of 400 IU/day for 2 months does not significantly affect lipid profiles and adiponectin levels."

"Hipertensi merupakan penyakit kardiovaskular yang paling umum dan paling banyak diderita, terutama oleh lanjut usia (lansia). Beberapa penelitian menunjukkan vitamin D berperan dalam tekanan darah. Pada lansia kadar 25(OH)D menurun karena kurangnya paparan sinar matahari dan asupan makanan yang mengandung vitamin D. Kekurangan vitamin D dapat dicegah, salah satunya dengan suplementasi. Penelitian ini merupakan penelitian eksperimental dengan desain uji acak terkendali tersamar ganda pada lansia di Panti Sosial Tresna Werdha Budi Mulia 1 bulan April sampai Juni 2023 dengan tujuan menganalisis pengaruh suplementasi vitamin D terhadap kadar 25(OH)D dan tekanan darah. Kadar 25(OH)D serum diperiksa menggunakan metode Chemiluminescent Immunoassay (CLIA), tekanan darah diperiksa menggunakan sphygmomanometer digital. Suplementasi diberikan 1 kali perhari selama 8 minggu, untuk kelompok kontrol diberikan plasebo sedangkan untuk kelompok perlakuan diberikan vitamin D dengan dosis 2000IU (subjek Insufisiensi) dan 4000IU (subjek defisiensi). 62 subjek penelitian berusia 60-89 tahun (median 67 tahun) ikut serta dalam penelitian ini dan terbagi secara random menjadi 30 subjek kelompok kontrol dan 32 subjek kelompok perlakuan. Peningkatan kadar 25(OH)D pada kelompok kontrol 23 ± 4,87 ng/mL menjadi 27,3 ± 7,34 ng/mL (p=0,000), pada kelompok perlakuan 17,9 ± 4,38 ng/mL menjadi 36,07 ± 9,84 ng/mL (p=0,000). Analisis rerata perubahan menunjukkan bahwa suplementasi vitamin D meningkatkan kadar 25(OH)D secara bermakna (D = 4,2 ± 2,47 ng/mL pada kelompok kontrol dan D = 18,17 ± 5,46 ng/mL pada kelompok perlakuan; p = 0.000). Penurunan tekanan darah sistolik pada kelompok kontrol 133,9(121 – 159,5) mmHg menjadi 129,3(96 – 159) mmHg (p=0,027), pada kelompok perlakuan 135,3(121 - 180) mmHg menjadi 126(101 - 153) mmgHg (p=0,000). Penurunan tekanan darah diastolik pada kelompok kontrol 89,6(80 - 105) mmHg menjadi 82,4(64 - 103) mmHg (p=0,000), pada kelompok perlakuan 89,2(81,5 – 98,5) mmHg menjadi 80,8 (67 – 90) mmHg (p=0,000). Akan tetapi, analisis rerata perubahan menunjukkan bahwa suplementasi vitamin D tidak menyebabkan penurunan tekanan darah sistolik (D = -4,6(-25 - -0,5) mmHg pada kelompok kontrol dan D = -9,2 (-20 - -27) mmHg pada kelompok perlakuan; p = 0.109) dan tekanan darah diastolik secara bermakna (D = -7,2 (-16 - -2) mmHg pada kelompok kontrol dan D = -8,4 (-14,5 - -8,5) mmHg pada kelompok perlakuan; p=0,559). Suplementasi vitamin D dapat meningkatkan kadar 25(OH)D secara bermakna, tetapi tidak menurunkan tekanan darah sistolik dan diastolik secara bermakna pada lansia.

---

Hypertension is the most common cardiovascular disease, especially in the elderly. Previous studies have reported that vitamin D play a role in blood pressure. In elderly, serum 25(OH)D levels decrease due to lack of sun exposure and intake of food sources of vitamin D. Vitamin D deficiency can be prevented by supplementation. This is an experimental study with double-blind randomized placebo-controlled trial (RCT) on elderly subjects at the Tresna Werdha Budi Mulia 1 Social Institution from April until June 2023 to analyze the effect of vitamin D supplementation on serum 25(OH)D levels and blood pressure. Serum 25(OH)D levels were examined using Chemiluminescent Immunoassay (CLIA) method, blood pressure was checked using digital sphygmomanometer. Supplementation was given once per day for 8 weeks, control group was given a placebo while treatment group was given vitamin D3 supplementation at dose of 2000IU (insufficiency subjects) and 4000IU (deficiency subjects). A total of 62 research subjects aged 60-89 years (median 67 years) participated in this study and randomized into 30 control group subjects and 32 treatment group subjects. The increase in serum 25(OH)D levels in the control group was 23 ± 4,87 ng/mL to 27,3 ± 7,34 ng/mL (p = 0.000), the treatment group was 17,9 ± 4,38 ng/mL to 36,07 ± 9,84 ng/mL (p = 0.000). Data analysis showed that vitamin D supplementation significantly increased 25(OH)D levels in the treatment group compared to the control group (D = 4,2 ± 2,47 ng/mL for control group and D = 18,17 ± 5,46 ng/mL for treatment group; p = 0.000). The decrease in systolic blood pressure in the control group was 133,9(121 – 159,5) mmHg to 129,3(96 – 159) mmHg (p = 0.027), the treatment group was 135,3(121 - 180) mmHg to 126(101 - 153) mmgHg (p = 0.000). The decrease in diastolic blood pressure in the control group was 89,6(80 - 105) mmHg to 82,4(64 - 103) mmHg (p = 0.000), the treatment group was 89,2(81,5 – 98,5) mmHg to 80,8 (67 – 90) mmHg (p = 0.000). However, data analysis showed that vitamin D supplementation did not cause a significant reduction in systolic blood pressure (D = -4,6(-25 - -0,5) mmHg for control group and D = -9,2 (-20 - -27) mmHg for treatment group; p = 0.109) and diastolic blood pressure in the treatment group compared to the control group (D = -7,2 (-16 - -2) mmHg for control group and D = -8,4(-14,5 - -8,5) mmHg for treatment group; p = 0.559). Vitamin D supplementation significantly increase serum 25(OH)D levels, but not significantly reduce systolic and diastolic blood pressure in the elderly."

"Background: the use of statin to lower blood cholesterol is often associated with bothersome adverse effects such as myopathy and liver dysfunction. NC120 is herbal lipid lowering drug containing red yeast rice (RYR) extract, guggulipid, and chromium picolinate, and expected to have better safety profile. The aim of this study was to evaluate the efficacy and safety profiles of NC120 in lowering blood lipid. Methods: this was a double blind randomized clinical trial comparing NC120 with placebo in subjects with hypercholesterolemia. Two capsules of NC120 or placebo were administered twice a day for 28 days. Blood total-cholesterol, LDL-cholesterol, and triglyceride were measured on day-0, day-7, and day-28. Unpaired t-test was used to compare study parameter between groups, and one-way ANOVA was used to compare within group. Results: 25 subjects received NC120 and 24 subjects received placebo. Significant decrease of total cholesterol and LDL-cholesterol were observed since day-7 in NC120 group, while the changes in placebo group were not significant at all time of observation. No significant decrease of triglyceride was observed in NC120 group and in placebo group. Side effects were minor and comparable between the two groups. Conclusion: NC120 is effective in reducing total cholesterol and LDL-cholesterol, but not triglyceride. This drug shows a good safety profile, and thus can be considered for patients who can not tolerate statin drugs."

"Nowadays, many children in developing countries are suffering from micro nutrient deficiencies (Lartey et at., 2000b; Zhao et al., 1998; van Stuijvenberg et al, 1999; Sempertegui et at, 1995). And the most prevalent ones are VAD (Vitamin A Deficiency), IDA (Iron Deficiency Anemia), IDD (Iodine Deficiency Disorder), and lately is zinc deficiency (Sandstead, 1991).The causes of micro nutrient deficiencies are varied and include inadequate dietary intakes (Robert et al, 2000), repeated infections (Khanum et al, 1998) and poor bioavailability from foods due to the presence of inhibitors or inadequate intake of dietary enhancers (Berdanier, 1998; Lunnerdal, 2000; de Pee et al, 1998; Donnen et al, 1996; Lartey et al, 2000a).Due to the roles of micronutrients in metabolic process, immune competence and taste acuity (Golden, 1995), previous findings showed that micronutrient deficiencies might impaired growth (Allen, 1994b; Rosado, 1999; Krieger et al, 1986; Simondon et al, 1996; Hambidge, 2000; Golden & Golden, 1981) and immune system (Black, 1998; Khanum et al, 1998; Semba et al, 1993). The reversibility of impairments caused by micronutrient deficiencies depends on the severity, duration, and stage of development. In some cases, micronutrient supplementation can correct the impairment right after a certain period of supplementation. Ninh et al (1996) stated that zinc deficiency among nutritionally deprived children may limit growth because the growth stimulating effects of zinc might be mediated through changes in circulating insulin-like growth factor (IGF). And after 5 months supplementation with daily-10 mg zinc, weight and height of growth-retarded children in supplemented group significantly increased compared to those of placebo group. In Uganda, zinc supplementation had a short-term effect (within 3 months) on weight gain and MUAC increment only among children from the school with the highest socioeconomic status (Kikafunda et al, 1998). Clinical vitamin A deficiency has been associated with poor child growth (Tarwotjo et al, 1992). Study in Zaire among moderately malnourished preschoolers found that high dose vitamin A supplementation (60 mg of oily solution of retinal palmitate, 30 mg if aged <12 months) increased MUAC and weight significantly compared to control group although without deforming at baseline (Donnen et al, 1998). In Indonesia, the intervention using vitamin A-monosodium glutamate did not merely result on increment of serum vitamin A level, but it also increased the linear growth of supplemented children compared to children in control group at every age (Muhilal et al, 1988). Similar with zinc and vitamin A, iron deficiency may also lead to slowing of growth in regarding to the increment of iron demands during periods of rapid growth and the adverse effects of morbidity. "

"Anak di bawah dua tahun berisiko tinggi untuk defisiensi zat gizi mikro khususnya defisiensi zat besi, sebagian dikarenakan praktek pemberian makanan tambahan yang salah. Untuk meningkatkan kualitas pemberian makanan tambahan, rekomendasi makanan tambahan (Complementary Feeding Recommendation - CFR) berbasis pangan lokal dibutuhkan. Suplementasi zat besi digunakan secara luas untuk menanggulangi defisiensi zat besi di negara berkembang; namun, efek dari suplementasi tersebut pada mikronutrien lain dan pertumbuhan menjadi perhatian tersendiri. Fortifikasi zat besi telah menunjukkan dampak negatif pada mikrobiota usus melalui peningkatan pertumbuhan bakteri patogen pada usus dikarenakan peningkatan besi yang diserap dan suplementasi zat besi mungkin memiliki dampak yang serupa pada mikrobiota usus tetapi masih belum pernah diteliti. Sebaliknya, jika suplementasi zat besi diberikan dengan optimalisasi diet menggunakan CFR, status gizi anak-anak akan meningkat dengan efek samping yang lebih kecil pada mikronutrien lain dan pertumbuhan. Studi ini meneliti efek dari suplementasi zat besi; dengan atau tanpa diet optimal; pada status mikronutrien, mikrobiota usus dan pertumbuhan anak-anak Myanmar yang berusia di bawah 2 tahun. Sebuah percobaan acak terkontrol (NCT01758159) dilaksanakan selama 24 minggu pada anak usia 12-23 bulan di Ayeyarwady, Myanmar. Optimalisasi CFR berbasis pangan lokal dikembangkan dengan pendekatan Linear Programming. Pengacakan berdasarkan Desa untuk CFR dan non-CFR dan berdasarkan anak (n=433) untuk suplemen besi atau placebo, menghasilkan: 1. kelompok CFR+Fe (n=112); 2. kelompok CFR (n=112); 3. kelompok Fe (n=105); or 4. kelompok pembanding (plasebo) (n=104). Ibu dari kelompok CFR menerima pendidikan CFR dan anak-anak dari kelompok Fe menerima 15 mg Ferric NaEDTA setiap hari. Serum Feritin, Transferin receptor (sTfR), Zinc, retinol-binding-protein (RBP), C-reactive protein dan α-1 acid glycoprotein; feces untuk melihat mikrobiota usus (Bifidobacteria, Lactobacilli, Enterobacteriaceae, E.coli, EPEC, EAEC dan ETEC) diukur pada awal dan akhir penelitian. Di awal penelitian, 88.4% anak mengalami anemia (Hb<110g/L); setelah dikontrol dengan infeksi, 74.4% mengalami defisiensi zat besi (SF<12μg/L dan/ atau sTfR>8.3mg/L) dan 68.9% mengalami anemia gizi besi (AGB) (Hb<110g/L and ID), 41.3% mempunyai kadar serum Send rendah (serum send <10.7µmol/L). Suplementasi besi menurunkan anemia, defisiensi zat besi dan AGB dengan atau tanpa pemberian diet optimal. Namun, suplementasi besi meningkatkan risiko serum Send rendah dan pendek (stunting) bila diberikan tanpa penambahan diet optimal. Efek samping ini tidak terlihat saat suplementasi tablet besi diberikan bersama dengan diet yang optimal. Tidak ada perbedaan yang nyata pada komposisi mikrobiota usus diantara semua kelompok. Suplementasi zat besi harus diberikan bersama dengan diet optimal untuk mengurangi efek samping baik pada kadar zat gizi mikro lainnya di dalam tubuh maupun pertumbuhan anak.

---

Children under 2-years of age are at high risk of micronutrient deficiencies especially iron deficiency (ID), partly due to poor complementary feeding practices. To improve feeding practices, local food-based complementary feeding recommendations (CFR) are needed. Iron supplementation is widely used to treat ID in developing countries; however, its potential effects on other micronutrients and growth are of concern. Iron fortification had shown negative impact on gut microbiota with increased growth of gut pathogens due to increased unabsorbed iron. It was assumed that iron supplementation may have similar impact on gut microbiota but has not yet been explored. On the other hand, if iron supplementation is given with optimized diet using CFRs, nutritional status of children would be improved with less adverse effects on other micronutrients status and growth.

The study investigated the effect of iron supplementation; given with or without optimized diet; on micronutrient status, gut microbiota and growth of under 2-year Myanmar children. A randomizedcontrolled trial (NCT01758159) was conducted for 24 weeks among 12-23 month old children from Ayeyarwady, Myanmar. Optimized CFRs based on locally available foods were developed by Linear Programming approach. Randomization by village for CFRs or non-CFRs and by child (n=433) for iron supplements or placebo, created: 1.CFR+Fe (n=112); 2.CFR-alone (n=112); 3.Fe-alone (n=105); or 4.Placebo (n=104) groups. Mothers from CFR-groups received education on CFRs and children from Fe groups received 15mg Ferric NaEDTA daily.

Serum for ferritin (SF), transferrinreceptor (sTfR), zinc, retinol-binding-protein (RBP), C-reactive protein and α-1 acid glycoprotein; stool for gut microbiota (Bifidobacteria, Lactobacilli, Enterobacteriaceae, E.coli, EPEC, EAEC and ETEC) were measured at baseline and endline. At baseline, 88.4% of children were anemic (Hb<110g/L); after adjusting for infection, 74.4% had ID (SF<12μg/L and/or sTfR>8.3mg/L) 68.9% had irondeficiency- anemia (IDA) (Hb<110g/L and ID), and 41.3% had low serum zinc status (serum zinc <10.7μmol/L).

Iron supplementation reduced anemia, ID and IDA whether or not it was given with optimized diet. However, iron supplementation increased the risk of low serum zinc and stunting when it is given without optimized diet. These adverse effects were not seen when iron supplementation was given with optimized diet. No significant difference was found in gut microbiota composition among groups. In conclusion, iron supplementation should be given together with optimized diet to reduce its adverse effect on other micronutrients status and growth to best improve nutritional status of these children."

"Purpose: This multicenter, randomized controlled study evaluates the safety of early oral feeding following gastrectomy, and its effect on the length of postoperative hospital stay.Methods: The subjects of this study were patients who underwent distal gastrectomy (DG) or total gastrectomy (TG) for gastric cancer between January 2014 and December 2015. Patients were randomly assigned to the early oral feeding group (intervention group) or the conventional postoperative management group (control group) for each procedure. We evaluated the length of postoperative hospital stay and the incidence of postoperative complications in each group.Results: No significant differences in length of postoperative stay were found between the intervention and control groups of the patients who underwent DG. The incidence of postoperative complications was significantly greater in the DG intervention group. In contrast, the length of postoperative stay was significantly shorter in the TG intervention group, although the TG group did not attain the established target sample size.Conclusion: Early oral feeding did not shorten the postoperative hospital stay after DG. The higher incidence of postoperative complications precluded the unselected adoption of early oral feeding for DG patients. Further confirmative studies are required to definitively establish the potential benefits of early oral feeding for TG patients."

"ABSTRACTBACKGROUND: Alphacalcidol, a vitamin D analog, shows immune regulatory potency as it works on the macrophage and T cell to control inflammation and T cell dysregulation in elderly. None has been known about its effect on elderly with various states of frailty syndrome, which have different level of chronic low grade inflammation. This study aimed to determine the effect of alphacalcidol on inflammatory cytokines (IL-6, IL-10, g-IFN ) and T cell subsets (CD4/CD8 ratio and CD8+ CD28-) of elderly with various stages of frailty syndrome. METHODS: from January to July 2017, a double blind randomized controlled trial (RCT) with allocation concealment, involving 110 elderly subjects from Geriatric Outpatient Clinic Cipto Mangunkusumo Hospital Jakarta, was conducted to measure the effect of 0.5 mcg alphacalcidol administration for 90 days to inflammatory cytokines (IL-6, IL-10, g-IFN) from PBMC culture supernatant, as well as CD4/CD8 and CD8+CD28- percentage using flow cytometry. Statistical analysis using SPSS version 20 was performed with t-test to measure mean difference. RESULTS: of 110 subjects involved in the RCT consisting of 27 fit, 27 pre-frail and 56 frail elderly, 25(OH)D serum level was found to be as low as 25.59 (12.2) ng/ml in alphacalcidol group and 28.27 (10.4) ng/ml in placebo group. Alphacalcidol did not decrease IL-6 (p=0.4) and g- IFN (p=0.001), but it increased IL-10 (p=0,005) and decreased IL6/IL10 ratio (p=0.008). Alphacalcidol increased CD4/CD8 ratio from 2.68 (SD 2.45) to 3.2 (SD 2.9); p=0.001 and decreased CD8+ CD28- percentage from 5.1 (SD 3.96) to 2.5 (1.5); p<0.001. Sub group analysis showed similar patterns in all frailty states. CONCLUSION: Alphacalcidol improves immune senescence by acting as anti-inflammatory agent through increased IL-10 and decreased IL6/IL-10 ratio and also improves cellular immunity through increased CD4/CD8 ratio and decreased CD8+ CD28- subset in elderly. This effect is not influenced by frailty state."

"ABSTRAKLatar belakangBerbagai studi terdahulu melaporkan bahwa alfacalcidol mampu meningkatkan kekuatan otot, keseimbangan dan signifikan dalam menurunkan kejadian jatuh pada ras Kaukasia. Namun belum ada penelitian yang membuktikan peran alfacalcidol terhadap mobilitas fungsional pada ras Asia.TujuanMengetahui pengaruh pemberian alfacacidol 0,5 µg selama 90 hari terhadap mobilitas fungsional dasar perempuan usia lanjut di Indonesia.MetodeDilakukan uji klinis acak tersamar ganda pada bulan April-September 2012 terhadap 95 pasien perempuan usia lanjut di Poliklinik Geriatri RS Cipto Mangunkusumo Jakarta, Indonesia. Subyek dibagi menjadi kelompok yang mendapat alfacalcidol dan kalsium 500 mg sehari sekali selama 90 hari dan kelompok yang mendapat plasebo dan kalsium 500 mg. Dilakukan uji timed-up and Go Test (TUG) pada awal dan akhir penelitian. Dilakukan analisis per protokol dan uji Mann-Whitney untuk melihat perbedaaan mobilitas fungsional pada kedua kelompok setelah intervensi.Hasil95 subyek dirandomisasi dan dibagi menjadi dua kelompok, terdiri dari 48 subyek yang mendapat plasebo dan 47 subyek mendapat alfacalcidol. Setelah tiga bulan pengamatan didapatkan perbaikan waktu uji TUG yang signifikan pada kedua kelompok (2,49 vs 1,83 detik; p<.0001). Terdapat perbaikan waktu uji TUG yang signifikan dari kelompok alfacalcidol dibandingkan dengan kelompok plasebo (9,01 vs.10,07 detik; p = 0.028).KesimpulanAlfacalcidol dengan dosis 0,5 µg satu kali per hari selama 90 hari terbukti mampu meningkatkan mobilitas fungsional dasar pada perempuan usia lanjut Indonesia.

---

ABSTRACTBackgroundPrevious studies reported the D-analog alfacalcidol, increases muscle power and balance and lead to a highly significant decreases in the number of fallers and falls in Caucasian elderly community-dwelling population.ObjectiveTo determine the effect of alfacalcidol on functional mobility in Indonesian elderly women community-dwelling population.MethodsA randomized, double-blind controlled trial was conducted in elderly women subjects geriatric clinic of Cipto Mangunkusumo National Hospital Jakarta Indonesia on April-September 2012. Intervention group was given 0,5 mcg alfacalcidol and 500 mg calcium daily for 90 days and another group was given placebo and 500 mg calcium. Balance test, Timed-up and Go Test (TUG) was measured at the beginning and after 3 months. Per protocol analysis to functional mobility after intervention between the two groups was performed.Results95 subjects were fulfiling study criteria and randomized into 2 groups, containing 47 subjects in alfacalcidol group and 48 subjects in placebo group. Both groups were comparable in all important prognostic factors including age, BMI, nutritional status, muscle strength. After three months the mean time in alfacalcidol group used for the TUG was decrease significantly by 2,49 s (p<.0001). There were significant improvement of the median time for TUG in the group that received alfacalcidol compared to placebo (9,01 vs.10,07 p = 0.028).ConclusionTreatment with 0.5 mg alfacalcidol with calcium effectively improved functional mobility in Indonesian elderly women."

"Ibu hamil yang berusia remaja seringkali mengalami ketidakpercayaan diri dalam merawat bayi. Kepercayaan diri dalam merawat bayi merupakan komponen penting dalam persiapan peran sebagai ibu. Diperlukan edukasi selama trimester III untuk mempersiapkan ibu dalam merawat bayi. Penelitian ini bertujuan untuk menguji pengaruh edukasi secara individu tentang perawatan bayi terhadap peningkatan maternal self-efficacy pada ibu hamil remaja trimester III. Desain penelitian menggunakan randomized controlled trial dengan jumlah responden 60 dibagi menjadi kelompok kontrol dan intervensi yang dilakukan randomisasi dan pelaksanaan penelitian menggunakan double blinding. Instrumen yang digunakan yaitu kuesioner The Self-Efficacy for Self and Health Care, Perceived Social Support from Family PSS-Fa dan Adolescent Prenatal Questionnaire APQ. Hasil penelitin menunjukkan ada pengaruh edukasi secara individu tentang perawatan bayi terhadap peningkatan rerata maternal self-efficacy sebesar 11,733 dengan nilai p= 0,001. Penelitian ini merekomendasikan pemberian edukasi secara individu tentang perawatan bayi pada ibu hamil remaja saat kunjungan ANC.

---

Teenage pregnancy women often experience self efficacy in caring for the baby. Confidence in caring for the baby is an important component in the preparation of the role of mother. Education is required during third trimester to prepare mother in caring for the baby. The purpose of this study to examine the effect individual education about baby care on improvement maternal self efficacy in adolescent pregnant third trimester.

The research design using randomized controlled trial with 60 respondents divided into control group and intervention, conducted randomization and implementation of research using double blinding. The instruments used Self Efficacy for Self and Health Care questionnaire, Perceived Social Support from Family PSS Fa and Adolescent Prenatal Questionnaire APQ.

The results of the study showed effect of individual education on infant care to increase maternal self efficacy with average of 11,733 with p 0,001. This study recommends providing individualized education on infant care in adolescent pregnant during an antenatal care."